Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H2 2020

European Healthtech startup funding raised during H2 2020.

In H2 2020, 305 European Healthtech companies closed 315 funding rounds and raised €3.7B in equity funding (excluding debt and grants), up 84.4% versus H2 2019. Debt rounds added €65M. UK led by capital raised, and Novo Holdings was the most active investor. Data as of 20 Nov 2026.

Equity funding
€3.7B
+84.4% vs H2 2019 · excl. debt & grants · +€65M debt
Funding rounds
315
+76.0% vs H2 2019
Companies
305
Top country
UK
Rank among sectors
#3
9.5% of sector funding
Debt financing
€65M
1.8% of total
Top-10 round share
24.4%
of disclosed capital
Rounds ≥ €100M
3

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H2 2020 — interactive chart.
Data table
FundingRounds
Jul€858M60
Aug€365M40
Sep€865M64
Oct€776M60
Nov€545M51
Dec€322M40

Top countries

by € raised
Healthtech — top countries by capital, H2 2020 — interactive chart.
Data table
Healthtech — top countries by capital, H2 2020
UK€722M
Israel€666M
Switzerland€582M
France€380M
Sweden€263M
Germany€218M
Spain€205M
Netherlands€198M

Stage mix

by € raised
Healthtech — stage mix, H2 2020 — interactive chart.
Data table
Healthtech — stage mix, H2 2020
Other€1.2B
Series C€816M
Series A€523M
Series B€470M
Series D+€398M
Seed€165M
Debt€65M
Early VC€47M
Growth/Late€42M
Crowdfunding€8.6M
Pre-Seed€7.7M
Grant€7.4M

Exits & M&A

12 Acquisition · 2 IPO

15 exits · €1.4B disclosed.

MYR GmbHAcquisitionOct 2020€1.1B
Nanox ImagingIPOAug 2020€140M
FiagonAcquisitionSep 2020€60M
OniAcquisitionNov 2020€40M

Top deals

largest disclosed rounds in H2 2020
CompanyStageDateAmount
KrySeries CJul 2020€140M
Freeline TherapeuticsSeries CJul 2020€107M
Atai Life SciencesSeries CNov 2020€105M
Sophia GeneticsSeries D+Oct 2020€94M
VectivbioOtherOct 2020€94M
Neogene TherapeuticsOtherSep 2020€93M
Freeline TherapeuticsSeries CJul 2020€71M
Lava TherapeuticsSeries CSep 2020€70M
MelioSeries CSep 2020€68M
PharvarisSeries CNov 2020€67M
Sight DiagnosticsSeries D+Jul 2020€61M
SightSeries D+Aug 2020€60M
Achilles TherapeuticsOtherNov 2020€59M
Imcheck TherapeuticsOtherSep 2020€54M
F2GOtherAug 2020€52M

Top investors

most active in H2 2020, by deal count